ArticleMedicine2025
Causal association between blood and urine biomarkers, immune cells, and bladder cancer: A Mendelian randomization and mediation analysis.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bladder cancer (BC) is influenced by genetic and environmental factors, with blood and urine biomarkers playing a critical role in its diagnosis and progression. However, establishing the causal association between these biomarkers and BC remains challenging due to confounding factors and reverse causation in traditional studies. Therefore, we conducted a Mendelian randomization (MR) analysis to assess the causal association between these biomarkers and BC. A bidirectional MR analysis was performed using pooled data from 35 blood and urine biomarkers, 731 immune cell types, and BC cases from the Genome-Wide Association of Transgenics and Circulating Metabolites study. Complementary analyses, including mediation analysis, 2-stage MR, and multivariate MR, were employed to investigate the potential mediating role of immune cells in this association. We further conducted sensitivity analyses to validate the stability and feasibility of our dataset. The analysis identified a causal association between BC and 2 biomarkers: calcium and sex hormone-binding globulin. Elevated calcium levels were associated with an increased risk of BC (inverse variance weighting: [OR] = 1.295, 95% [CI] = 1.062-1.578, P = .011), while higher sex hormone-binding globulin levels were linked to a decreased risk (inverse variance weighting: OR = 0.857, 95% CI = 0.741-0.991, P = .037). Notably, CD20 expression on IgD⁻ CD24⁻ B cells appeared to attenuate the positive association between calcium and BC. This study reinforces the association between specific blood and urine biomarkers and the risk of developing BC. It also highlights the mediating role of CD20 on IgD⁻ CD24⁻ B cells in the causal pathways linking these biomarkers to BC. These insights enhance our understanding of BC pathogenesis and may guide the development of targeted diagnostic and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.